CAM
CRL icon

Cresset Asset Management’s Charles River Laboratories CRL Stock Holding History

Cresset Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,647
Closed -$802K – 1765
2026
Q1 		$802K Sell
4,647
-174
-4% -$32.3K ﹤0.01% 877
2025
Q4 		$962K Sell
4,821
-4
-0.1% -$726 ﹤0.01% 805
2025
Q3 		$755K Buy
4,825
+135
+3% +$21.4K ﹤0.01% 858
2025
Q2 		$712K Sell
4,690
-961
-17% -$128K ﹤0.01% 795
2025
Q1 		$851K Buy
5,651
+24
+0.4% +$4.02K ﹤0.01% 842
2024
Q4 		$1.04M Sell
5,627
-1,127
-17% -$217K 0.01% 781
2024
Q3 		$1.33M Buy
6,754
+811
+14% +$169K 0.01% 1020
2024
Q2 		$1.23M Sell
5,943
-105
-2% -$23.8K 0.01% 959
2024
Q1 		$1.64M Sell
6,048
-26
-0.4% -$6.21K 0.01% 746
2023
Q4 		$1.44M Sell
6,074
-876
-13% -$172K 0.01% 733
2023
Q3 		$1.36M Buy
6,950
+2,558
+58% +$525K 0.01% 696
2023
Q2 		$923K Buy
+4,392
New +$874K ﹤0.01% 982
2022
Q1 		– Sell
-666
Closed -$250K – 1019
2021
Q4 		$250K Buy
666
+1
+0.2% +$389 ﹤0.01% 955
2021
Q3 		$274K Buy
665
+124
+23% +$51.5K ﹤0.01% 894
2021
Q2 		$200K Buy
+541
New +$181K ﹤0.01% 956
2019
Q2 		– Sell
-324
Closed -$47K – 727
2019
Q1 		$47K Buy
324
+157
+94% +$20.6K ﹤0.01% 803
2018
Q4 		$19K Buy
+167
New +$20.9K ﹤0.01% 715

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Cresset Asset Management's CRL Position: Q2 2026 in Review

Cresset Asset Management sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 4,647 shares — an estimated $802K sold.

Cresset Asset Management first reported a position in CRL in Q4 2018 and held it in 17 quarters. The position peaked at $1.64M in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Cresset Asset Management reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Cresset Asset Management sold 4,647 Charles River Laboratories shares in Q2 2026, an estimated $802K.
  • Cresset Asset Management first reported a position in Charles River Laboratories in Q4 2018 and held it in 17 quarters.
  • Cresset Asset Management's Charles River Laboratories position peaked at $1.64M in Q1 2024.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.